Some visit links earn us a commission.

Lowest compounded tirzepatide drug price in Maryland 2026: $69 a month, plus yearly membership

Compounded tirzepatide, a pharmacy-made version that is not Zepbound or Mounjaro, ships to Maryland from four of our partner programs. The lowest of the programs we track is $69 a month at Collective, plus a yearly membership, read on November 11, 2026.

Medicaid for weight loss
Not covered
Partner programs that ship here
Eden, Collective, SnagRx and CoreAge Rx
Adults with obesity
33.1% (CDC, 2025)

Compounded tirzepatide prices in Maryland

ProgramMonthly priceCheckedProgram's site
Eden logoEden$129 a monthNovember 11, 2026Check price →
Collective logoCollective$69 a month, plus yearly membershipNovember 11, 2026Check price →
SnagRx logoSnagRx$149 a month, or $119 a month paid 12 months up frontNovember 11, 2026
CoreAge Rx logoCoreAge Rx$129 a monthNovember 11, 2026

Eden, Collective, SnagRx and CoreAge Rx pay GLP Chart when you buy through our links.

What a year of compounded tirzepatide costs in Maryland

  • Eden ships to Maryland at $1,548 for 12 months.
  • Collective ships to Maryland at $1,027 for 12 months with its membership.
  • SnagRx ships to Maryland at $1,788 for 12 months, or $1,428 if Maryland buyers pay 12 months up front.
  • CoreAge Rx ships to Maryland at $1,548 for 12 months.

For compounded semaglutide, Maryland buyers pay from $59 a month at Collective, plus a yearly membership, against $69 for compounded tirzepatide in Maryland.

Does Maryland Medicaid cover Zepbound?

Maryland Medicaid does not cover Zepbound for weight loss. It does cover Zepbound for obstructive sleep apnea, with prior authorization. Maryland Medicaid plans include Aetna Better Health of Maryland, CareFirst BlueCross BlueShield Community Health Plan, Kaiser Permanente of the Mid-Atlantic States and Maryland Physicians Care. No Maryland Medicaid plan pays for compounded tirzepatide, so it is a cash purchase. Maryland Medicaid GLP-1 rules.

Obesity in Maryland

33.1% of adults in Maryland had obesity in 2025, by the CDC's state survey, against 33.5% for the US as a whole. That puts Maryland 0.4 points below the national rate, about 3 in 10 Maryland adults.

More for Maryland

Compounded tirzepatide is made by a licensed pharmacy to a prescription and is not FDA-approved. A prescriber decides whether it suits you.